While it is theoretically possible to petition the Patent Office to compel rulemaking, petitioner faces a heavy burden to succeed, as manifested by Service Women’s Action Network v. Sec’y of ...
Recently in Secure Web Conference Corp. v. Microsoft, __Fed App’x __ (Fed. Cir. 2016)(Stoll, J.), the panel explained its decision in terms of the "essence of the invention”. Attached is an excerpt ...
In Top Ten No. (3), Cuozzo Speed Technologies LLC v. Lee (Top Ten Patent Cases, attached), a subsidiary issue is raised in this challenge against the “broadest reasonable interpretation” rule ...
Today in Wallace v. Ideavillage Products Corp., __ Fed App’x __ (Fed. Cir. 2016)(Newman, J.), in the course of a routine affirmance in a pro se appeal denying infringement of ...
Prospective amici in support of petitioner in Sequenom, Inc. v. Ariosa Diagnostics, Inc., Supreme Court No. 15A871, would do well to defer a final decision whether to join this case as ...
Today in the Humira® case, Fujifilm Kyowa Biologics Co., Ltd. v. Abbvie Biotechnology Limited, [2016] EWHC 374(IP)(Ch)(High Court 2016)(Carr, J.), the trial court issued an opinion involving parallel proceedings within ...
Whither Patent “Evergreening”, the Spangenberg Critique Erich Spangenberg has authored an attack on the current Administration and its Under Secretary in charge of the patent system [FNa]. His focus is ...
Responsive to the previous note (reproduced below) an astute observer points to the limited scope of post-grant review in a controversial Patent Office decision. The observer cites a PTAB decision ...
Top Ten No. (1) Sequenom v. Ariosa: From the standpoint of the law of patent-eligibility under 35 USC §101, this is a most important case. The petition is now due ...
Further to the note earlier today (attached below), this morning the Court denied petitions for certiorari in ePlus and Arthrex. TopTenCases2016Feb29 Regards Hal